iShares US Pharmaceuticals ETF
IHE
IHE
155 hedge funds and large institutions have $359M invested in iShares US Pharmaceuticals ETF in 2024 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 42 increasing their positions, 32 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
155
Holders Change
+12
Holders Change %
+8.39%
% of All Funds
2.06%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
30
Increased
42
Reduced
32
Closed
16
Calls
$7K
Puts
–
Net Calls
+$7K
Net Calls Change
+$7K
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
$12.4M |
| 2 |
Morgan Stanley
New York
|
$25M |
| 3 |
Two Sigma Investments
New York
|
$4.43M |
| 4 |
PCA
Pallas Capital Advisors
Braintree,
Massachusetts
|
$3.83M |
| 5 |
Goldman Sachs
New York
|
$6.57M |
